Dr. Michael Hafran joins Dr. Michael Koren to discuss new investigational gene editing therapies. They talk about what genes and gene editing are, the history of gene editing, and some of the FDA-approved therapies on the market today. They also address fears people have about gene editing and clinical trials, explain the long and intensive safety measures in place, and reveal that these therapies aren't too different from what the body does naturally, just in a more guided and specific way to address genetic problems. They finish up by talking about an investigational medication designed to reduce an overactive cholesterol-related gene and lower the incidence of heart problems.
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Michael Koren. Innehållet i podden är skapat av Dr. Michael Koren och inte av,
eller tillsammans med, Poddtoppen.
